Author Correction: The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression (Nature, (2016), 532, 7598, (245-249), 10.1038/nature17403);The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression

Nature

Volumn 532, Issue 7598, 2016, Pages 245-249

  Seifert, Lena ^a   Werba, Gregor ^a   Tiwari, Shaun ^a   Giao Ly, Nancy Ngoc ^a   Alothman, Sara ^a   Alqunaibit, Dalia ^a   Avanzi, Antonina ^a   Barilla, Rocky ^a   Daley, Donnele ^a   Greco, Stephanie H ^a   Torres Hernandez, Alejandro ^a   Pergamo, Matthew ^b   Ochi, Atsuo ^a   Zambirinis, Constantinos P ^a   Pansari, Mridul ^a   Rendon, Mauricio ^a   Tippens, Daniel ^a   Hundeyin, Mautin ^a   Mani, Vishnu R ^a   Hajdu, Cristina ^b   Engle, Dannielle ^c   Miller, George ^a,b   more..

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; GEMCITABINE; PROTEIN; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 3; UNCLASSIFIED DRUG; CLECSF8 PROTEIN, MOUSE; CXCL1 PROTEIN, HUMAN; CXCL1 PROTEIN, MOUSE; DEOXYCYTIDINE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LECTIN; MEMBRANE PROTEIN; RALBP1 PROTEIN, MOUSE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, MOUSE;

APOPTOSIS; ATTRACTANT; CANCER; CELLS AND CELL COMPONENTS; CHEMOTHERAPY; DRUG; IMMUNITY; INHIBITION; LIGAND; OXYGEN; PHENOTYPE; PROTEIN; RODENT; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; C57BL MOUSE; DISEASE COURSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM; NECROSIS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

MUS;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CXCL1; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GTPASE-ACTIVATING PROTEINS; HUMANS; IMMUNE TOLERANCE; LECTINS, C-TYPE; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NECROSIS; PANCREATIC NEOPLASMS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84964317387     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-021-03322-8     Document Type: Erratum

References (26)

1. Johnstone, R. W., Ruefli, A. A., Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153-164 (2002).
2. Fernald, K., Kurokawa, M. Evading apoptosis in cancer. Trends Cell Biol. 23, 620-633 (2013).
3. Lowe, S. W., Lin, A. W. Apoptosis in cancer. Carcinogenesis 21, 485-495 (2000).
4. Holler, N. et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol. 1, 489-495 (2000).
5. Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., Vandenabeele, P. Regulated necrosis: the expanding network of nonapoptotic cell death pathways. Nature Rev. Mol. Cell Biol. 15, 135-147 (2014).
6. Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., Kroemer, G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Rev. Mol. Cell Biol. 11, 700-714 (2010).
7. Nagy, A. et al. Copy number of cancer genes predict tumor grade and survival of pancreatic cancer patients. Anticancer Res. 21, 1321-1325 (2001).
8. Plath, T. et al. Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis. J. Natl. Cancer Inst. 94, 129-142 (2002).
9. Rosty, C. et al. p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis. Am. J. Surg. Pathol. 27, 1495-1501 (2003).
10. Takahashi, H. et al. Simultaneous knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax activation in pancreatic cancer cells. Biochim. Biophys. Acta 1833, 2980-2987 (2013).
11. Ochi, A. et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J. Clin. Invest. 122, 4118-4129 (2012).
12. He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-? . Cell 137, 1100-1111 (2009).
13. Yatim, N. et al. RIPK1 and NF-? B signaling in dying cells determines cross-priming of CD8+ T cells. Science 350, 328-334 (2015).
14. Connolly, M. K. et al. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J. Leukoc. Biol. 87, 713-725 (2010).
15. Acharyya, S. et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150, 165-178 (2012).
16. Yamasaki, S. et al. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nature Immunol. 9, 1179-1188 (2008).
17. Wells, C. A. et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 180, 7404-7413 (2008).
18. Newton, K., Sun, X., Dixit, V. M. Kinase RIP3 is dispensable for normal NF-? Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24, 1464-1469 (2004).
19. Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450 (2003).
20. Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483 (2005).
21. Zambirinis, C. P. et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J. Exp. Med. 212, 2077-2094 (2015).
22. Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G., Bar-Sagi, D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21, 836-847 (2012).
23. Bedrosian, A. S. et al. Dendritic cells promote pancreatic viability in mice with acute pancreatitis. Gastroenterology 141, 1915-1926 (2011).
24. Ochi, A. et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J. Exp. Med. 209, 1671-1687 (2012).
25. Hruban, R. H. et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 25, 579-586 (2001).
26. Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002).